Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Copper
Drug ID BADD_D00529
Description Copper is a transition metal and a trace element in the body. It is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label]. Copper is commonly used in contraceptive intrauterine devices (IUD) [L801].
Indications and Usage For use in the supplementation of total parenteral nutrition and in contraception with intrauterine devices [FDA Label] [L801].
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB09130
KEGG ID Not Available
MeSH ID D003300
PubChem ID 23978
TTD Drug ID D01WMJ
NDC Product Code 68428-349; 82815-0001; 62106-5020; 51285-204; 0220-1623; 0220-1635; 59365-5128; 68428-140; 64117-958; 0220-1636
UNII 789U1901C5
Synonyms Copper | Copper-63 | Copper 63
Chemical Information
Molecular Formula Cu
CAS Registry Number 7440-50-8
SMILES [Cu]
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Discomfort08.01.08.003-Not Available
Dysmenorrhoea21.01.01.002-
Dyspareunia21.03.02.016; 19.08.05.004-
Ectopic pregnancy18.02.02.002-Not Available
Endometrial disorder21.07.01.001-Not Available
Endometrial hyperplasia21.07.01.002-Not Available
Endometriosis21.07.01.004-Not Available
Flank pain20.02.03.006; 15.03.04.003; 08.01.08.007-
Groin pain15.03.02.004-Not Available
Haemoglobin13.01.05.018--Not Available
Haemorrhage in pregnancy24.07.03.015; 18.02.01.003-Not Available
Hypomenorrhoea21.01.02.002; 05.05.01.006-Not Available
Infertility21.03.02.001-Not Available
Infertility female21.03.02.017-Not Available
Large intestine perforation12.02.03.005; 07.04.06.005-
Menometrorrhagia21.01.03.001-Not Available
Menopausal symptoms21.02.02.002-Not Available
Menstrual disorder21.01.01.004-Not Available
Menstruation delayed21.01.02.003; 05.05.01.010-Not Available
Menstruation irregular21.01.01.005; 05.05.01.008-
Micturition urgency20.02.02.006-
Muscle spasms15.05.03.004-
Neoplasm malignant16.16.01.001--Not Available
Nephropathy toxic20.05.03.002; 12.03.01.010--Not Available
Oligomenorrhoea21.01.02.004; 05.05.01.011-Not Available
Ovarian cyst21.11.01.002; 16.04.03.001-Not Available
Ovarian enlargement21.11.02.001-Not Available
Ovarian germ cell teratoma benign16.04.03.002; 21.11.01.004-Not Available
Ovulation pain21.01.01.016-
Pain08.01.08.004-
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 6 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene